Fondaparinux Sodium
ATC B01AX05 · 5 markets · 17 records
AU 4 records · 4 shown of 4
- 10 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
- 7.5 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
- 5 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
- 2.5 mginjectionARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe
SG 4 records · 3 shown of 3
- 2.5 mg/0.5 mLinjectionARIXTRA solution forDIVITI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 2.5MG/0.5ML
- 7.5 mg/0.6 mLinjectionARIXTRA solution for
- 5 mg/0.4 mLinjectionARIXTRA solution for
FR 4 records · 4 shown of 4
- 2.5 mg/0.5 mLinjectionARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie
- 7.5 mg/0.6 mLinjectionARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie
- 5 mg/0.4 mLinjectionARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie
- 10 mg/0.8 mLinjectionARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | AU | SG | HK | EU | FR |
|---|---|---|---|---|---|
| 2.5 mg/0.5 mL injection | ARIXTRA solution for DIVITI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 2.5MG/0.5ML | ARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie | |||
| 7.5 mg/0.6 mL injection | ARIXTRA solution for | ARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie | |||
| 5 mg/0.4 mL injection | ARIXTRA solution for | ARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie | |||
| 10 mg injection | ARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe | ||||
| 10 mg/0.8 mL injection | ARIXTRA 10 mg/0,8 ml, solution injectable en seringue pré-remplie | ||||
| 7.5 mg injection | ARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe | ||||
| 5 mg injection | ARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe | ||||
| 2.5 mg injection | ARIXTRA fondaparinux sodium 2.5mg/0.5mL solution for injection syringe | ||||
unknown | ARIXTRA PRE-FILL SYR FOR INJ 2.5MG/0.5ML ARIXTRA SOLUTION FOR INJ 7.5MG/0.6ML | Arixtra |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.